Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRETENSION II bedtime versus morning aspirin study
NL-OMON34181Phase 3Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aspirin in cardiac morbidity and hypertension (HTN) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: 24-hour ambulatory blood pressure. Started Jun 2011; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
cardiac morbidityhypertension (HTN)
Beyond the preview
Go deeper on NL-OMON34181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34181.